Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. Eur J Cancer. 2022 09; 172:367-386.

View in: PubMed

subject areas

Adolescent
Child
Consensus
Humans
Molecular Diagnostic Techniques
Neoplasm Recurrence, Local
Prospective Studies
Rhabdomyosarcoma
Rhabdomyosarcoma, Embryonal
Risk Assessment
Soft Tissue Neoplasms

authors with profiles

Samuel L. Volchenboum